Polaryx Therapeutics, Inc. SEC EDGAR Filings (CIK 0002075320)

SEC EDGAR filings, ownership reports, and insider transactions for Polaryx Therapeutics, Inc..

Symbol
PLYX
Industry
Pharmaceutical Preparations (Office Of Life Sciences)
Business address
140 East Ridgewood Avenue, Suite 415, South Tower, Paramus, NJ, 07652
State of incorporation
WY
Fiscal year end
31 December
⭐ Add to watchlist ⭐
Get insider transactions for this issuer
Polaryx Therapeutics, Inc. has filed 22 SEC EDGAR filings since 05 Aug 2025

Latest Filings

Recent SEC filings for Polaryx Therapeutics, Inc. including 4, SCHEDULE 13D, 424B4 and more.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 20 Feb 2026 18 Feb 2026
SCHEDULE 13D Open SCHEDULE 13D document View SEC filing for SCHEDULE 13D 05 Feb 2026 005-95464
424B4 Open 424B4 document View SEC filing for 424B4 PROSPECTUS 02 Feb 2026 333-291681
EFFECT Open EFFECT document View SEC filing for EFFECT 29 Jan 2026 333-291681
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 29 Jan 2026 29 Jan 2026
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 29 Jan 2026 29 Jan 2026
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 29 Jan 2026 29 Jan 2026
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 29 Jan 2026 29 Jan 2026
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 29 Jan 2026 29 Jan 2026
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 29 Jan 2026 29 Jan 2026
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 29 Jan 2026 29 Jan 2026
CERT Open CERT document View SEC filing for CERT 28 Jan 2026 001-43080
8-A12B Open 8-A12B document View SEC filing for 8-A12B FOR REGISTRATION OF CERTAIN CLASSES 27 Jan 2026 001-43080
S-1/A Open S-1/A document | Open XBRL data View SEC filing for S-1/A REGISTRATION STATEMENT 27 Jan 2026 333-291681
S-1/A Open S-1/A document View SEC filing for S-1/A REGISTRATION STATEMENT 14 Jan 2026 333-291681
S-1 Open S-1 document | Open XBRL data View SEC filing for S-1 REGISTRATION STATEMENT 21 Nov 2025 333-291681
C-U Open C-U document View SEC filing for C-U 31 Oct 2025 020-36323
C-U Open C-U document View SEC filing for C-U 27 Oct 2025 020-36323
C/A Open C/A document View SEC filing for C/A 01 Oct 2025 020-36323
DRS/A Open DRS/A document View SEC filing for DRS/A 19 Sep 2025 377-08292
C Open C document View SEC filing for C 03 Sep 2025 020-36323
DRS Open DRS document View SEC filing for DRS 05 Aug 2025 377-08292

About this filer

Polaryx Therapeutics, Inc. files with the SEC under CIK 0002075320. This page aggregates EDGAR filings and related ownership activity.

Industry: Pharmaceutical Preparations.

See insider transactions for this issuer.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages